Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Neogenomics Inc (NEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Fluidigm Corp is Among the Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (FLDM , NEO , PRAH , TMO , PKI )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

NEO : 19.43 (+0.41%)
PRAH : 107.41 (+1.10%)
FLDM : 13.37 (-3.88%)
Relatively Good Performance Detected in Shares of Bruker Corp in the Life Sciences Tools & Services Industry (BRKR , NEO , WAT , TMO , FLDM )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

BRKR : 38.16 (+0.10%)
NEO : 19.43 (+0.41%)
WAT : 248.15 (+0.76%)
Neogenomics Inc Shares Up 52.7% Since SmarTrend's Buy Recommendation (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on January 8th, 2019 at $13.03. In approximately 2 months, Neogenomics Inc has returned 52.71% as of today's recent price of $19.89.

NEO : 19.43 (+0.41%)
Relatively Good Performance Detected in Shares of Fluidigm Corp in the Life Sciences Tools & Services Industry (FLDM , NEO , TMO , WAT , PRAH )

Below are the top five companies in the Life Sciences Tools & Services industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks...

TMO : 269.99 (+0.44%)
NEO : 19.43 (+0.41%)
FLDM : 13.37 (-3.88%)
Neogenomics Inc Has Returned 44.0% Since SmarTrend Recommendation (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on January 8th, 2019 at $13.03. In approximately 2 months, Neogenomics Inc has returned 44.03% as of today's recent price of $18.76.

NEO : 19.43 (+0.41%)
Nanostring Techn has the Best Relative Performance in the Life Sciences Tools & Services Industry (NSTG , NEO , CRL , PACB , A )

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

NEO : 19.43 (+0.41%)
CRL : 142.63 (+0.20%)
NSTG : 23.53 (+0.81%)
NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference

FT MYERS, FL / ACCESSWIRE / March 7, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced that Sharon Virag, Chief Financial Officer, and...

NEO : 19.43 (+0.41%)
50.5% Return Seen to Date on SmarTrend Neogenomics Inc Call (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on January 8th, 2019 at $13.03. In approximately 2 months, Neogenomics Inc has returned 50.48% as of today's recent price of $19.60.

NEO : 19.43 (+0.41%)
Neogenomics Inc Shares Up 42.2% Since SmarTrend's Buy Recommendation (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on January 8th, 2019 at $13.03. In approximately 1 month, Neogenomics Inc has returned 42.19% as of today's recent price of $18.52.

NEO : 19.43 (+0.41%)
NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter and full year 2018.

NEO : 19.43 (+0.41%)
NeoGenomics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 19, 2019 / NeoGenomics, Inc. (NASDAQ: ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on February 19, 2019 at 8:30 AM Eastern...

NEO : 19.43 (+0.41%)
Zacks.com featured highlights include: Ready Capital, Gladstone, NeoGenomics, Digi and Paramount

Zacks.com featured highlights include: Ready Capital, Gladstone, NeoGenomics, Digi and Paramount

RC : 15.48 (+0.78%)
NEO : 19.43 (+0.41%)
DGII : 12.49 (+1.05%)
GAIN : 11.58 (+0.35%)
PGRE : 14.10 (+0.28%)
NeoGenomics (NEO) Reports Next Week: What to Know Ahead of the Release

NeoGenomics (NEO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NEO : 19.43 (+0.41%)
5 Breakout Stocks for Stellar Returns

This method involves zeroing in on stocks whose prices vary within a narrow band.

RC : 15.48 (+0.78%)
NEO : 19.43 (+0.41%)
DGII : 12.49 (+1.05%)
GAIN : 11.58 (+0.35%)
PGRE : 14.10 (+0.28%)
Neogenomics Inc Shares Up 29.8% Since SmarTrend's Buy Recommendation (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on January 8th, 2019 at $13.03. In approximately 4 weeks, Neogenomics Inc has returned 29.83% as of today's recent price of $16.91.

NEO : 19.43 (+0.41%)
Neogenomics Inc Has Returned 28.0% Since SmarTrend Recommendation (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on January 8th, 2019 at $13.03. In approximately 3 weeks, Neogenomics Inc has returned 27.98% as of today's recent price of $16.67.

NEO : 19.43 (+0.41%)
Is NeoGenomics (NEO) Outperforming Other Medical Stocks This Year?

Is (NEO) Outperforming Other Medical Stocks This Year?

NEO : 19.43 (+0.41%)
NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its fourth quarter and fiscal year 2018 financial results on Tuesday,...

NEO : 19.43 (+0.41%)
Report: Developing Opportunities within Macerich, Illinois Tool Works, NeoGenomics, Bunge, Dolby Laboratories, and Cracker Barrel Old Country Store -- Future Expectations, Projections Moving into 2019

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Macerich Company (NYSE:MAC),...

BG : 51.45 (+0.02%)
CBRL : 159.39 (-1.07%)
NEO : 19.43 (+0.41%)
DLB : 62.87 (-0.59%)
ITW : 142.76 (+0.51%)
MAC : 43.89 (+1.57%)
NeoGenomics Set to Join S&P SmallCap 600

NeoGenomics Inc. (NASD: NEO) will replace Engility Holdings Inc. (NYSE: EGL) in the S&P SmallCap 600 effective prior to the open of trading on Monday, January 14, 2019. S&P MidCap 400 constituent Science...

NEO : 19.43 (+0.41%)
SPGI : 204.77 (-0.12%)
EGL : 29.10 (+0.24%)
SAIC : 73.15 (+2.84%)

Van Meerten Stock Picks

Trilogy Metals - Pick of the Day
My Stock Pick of the Day belongs metal mining company Trilogy Metals(TMQ).
TMQ +0.06
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar